Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.3849
-0.0251 (-6.12%)
At close: Aug 28, 2026, 4:00 PM EDT
0.4000
+0.0151 (3.92%)
After-hours: Aug 28, 2026, 4:15 PM EDT
Alps Group Market Cap
Alps Group has a market cap or net worth of $64.05 million as of August 28, 2026. Its market cap has increased by 46.43% in one year.
Market Cap
64.05M
Enterprise Value
64.18M
1-Year Change
46.43%
Ranking
Category
Stock Price
$0.38
ChartMarket Cap Chart
Since December 23, 2021, Alps Group's market cap has decreased from $143.00M to $64.05M, a decrease of -55.21%. That is a compound annual growth rate of -15.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 64.05M | -55.73% |
| Dec 31, 2025 | 144.67M | 230.19% |
| Dec 30, 2024 | 43.81M | -50.64% |
| Dec 29, 2023 | 88.76M | -41.77% |
| Dec 30, 2022 | 152.44M | 6.93% |
| Dec 30, 2021 | 142.56M | -0.30% |
| Dec 23, 2021 | 143.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioStem Technologies | 69.26M |
| PMV Pharmaceuticals | 68.96M |
| eXoZymes | 68.03M |
| Champions Oncology | 67.94M |
| INmune Bio | 66.89M |
| Boundless Bio | 66.42M |
| MindWalk Holdings | 66.25M |
| Edesa Biotech | 66.21M |